Reprogramming the Human Glioma Genome

重新编程人类神经胶质瘤基因组

基本信息

  • 批准号:
    9064865
  • 负责人:
  • 金额:
    $ 24.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-05-15 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): SUMMARY Malignant gliomas, the most deadly neurological disease in the brain, are essentially incurable due to their rapid growth and very invasive nature. One paradigm-shifting therapeutic approach to eliminating brain tumors is to change the fate of glioma cells so that they are non-proliferative and non-invasive. We previously showed that virus-mediated expression of two transcription factors directly converts human fibroblasts to neurons with extremely high efficiency. Unexpectedly, our preliminary results also revealed that malignant human glioma cells can be very efficiently converted to neuron-like cells, which are no longer proliferative or invasive. Even the cells that are transduced but not yet fate-converted stopped proliferation, indicating a dominant role for these factors in governing the behavior of human glioma cells. Our preliminary results further show that majority of the in vivo converted cells cannot survive in the adult brain environment. Based on these very exciting findings, we propose to tease out the molecular mechanism underlying forced terminal differentiation of human glioma cells that is mediated by a synergistic action of two transcription factors. We will specifically focus on transcriptome, cistrome, global chromatin structure and epigenetic modifications during the reprogramming process. Results from this study may lead to the identification of nodal points controlling the behavior of human glioma cells, which can be targeted for developing novel therapeutics against the most deadly brain disease-glioblastoma.
 描述(由申请人提供):概述恶性神经胶质瘤是大脑中最致命的神经系统疾病,由于其快速生长和极具侵袭性,基本上是不可治愈的。消除脑肿瘤的一种范式转变治疗方法是改变神经胶质瘤细胞的命运,使它们是非增殖性和非侵入性的。我们先前表明,病毒介导的两种转录因子的表达直接将人成纤维细胞转化为神经元,具有极高的效率。出乎意料的是,我们的初步结果还显示,恶性人脑胶质瘤细胞可以非常有效地转化为神经元样细胞,这些细胞不再具有增殖性或侵袭性。即使是转导但尚未发生命运转换的细胞也停止了增殖,这表明这些因子在控制人类神经胶质瘤细胞的行为中起着主导作用。我们的初步结果进一步表明,大多数体内转化的细胞不能在成人脑环境中存活。基于这些非常令人兴奋的发现,我们建议梳理出的分子机制,迫使终末分化的人脑胶质瘤细胞是由两个转录因子的协同作用介导的。我们将特别关注转录组,顺式组,全局染色质结构和重编程过程中的表观遗传修饰。这项研究的结果可能会导致控制人类神经胶质瘤细胞行为的节点的识别,这些节点可以用于开发针对最致命的脑部疾病胶质母细胞瘤的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chun-Li Zhang其他文献

Chun-Li Zhang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chun-Li Zhang', 18)}}的其他基金

PAX6-induced adult neurogenesis
PAX6诱导的成体神经发生
  • 批准号:
    10537755
  • 财政年份:
    2022
  • 资助金额:
    $ 24.28万
  • 项目类别:
PAX6-induced adult neurogenesis
PAX6诱导的成体神经发生
  • 批准号:
    10614061
  • 财政年份:
    2022
  • 资助金额:
    $ 24.28万
  • 项目类别:
In vivo reprogramming of NG2 glia for neurogenesis
NG2 神经胶质细胞体内重编程促进神经发生
  • 批准号:
    10240711
  • 财政年份:
    2020
  • 资助金额:
    $ 24.28万
  • 项目类别:
In Vivo Reprogramming of NG2 Glia for Neurogenesis
NG2 神经胶质细胞的体内重编程促进神经发生
  • 批准号:
    10685553
  • 财政年份:
    2020
  • 资助金额:
    $ 24.28万
  • 项目类别:
In vivo reprogramming of NG2 glia for neurogenesis
NG2 神经胶质细胞体内重编程促进神经发生
  • 批准号:
    10065249
  • 财政年份:
    2020
  • 资助金额:
    $ 24.28万
  • 项目类别:
In vivo reprogramming of NG2 glia for neurogenesis
NG2 神经胶质细胞体内重编程促进神经发生
  • 批准号:
    10475224
  • 财政年份:
    2020
  • 资助金额:
    $ 24.28万
  • 项目类别:
Chemical Reprogramming of Traumatic Brain Injury
创伤性脑损伤的化学重编程
  • 批准号:
    9380654
  • 财政年份:
    2017
  • 资助金额:
    $ 24.28万
  • 项目类别:
Induced Adult Neurogenesis for Parkinson's Disease
帕金森病的诱导成人神经发生
  • 批准号:
    9176194
  • 财政年份:
    2016
  • 资助金额:
    $ 24.28万
  • 项目类别:
Induced Adult Neurogenesis for Parkinson's Disease
帕金森病的诱导成人神经发生
  • 批准号:
    9751421
  • 财政年份:
    2016
  • 资助金额:
    $ 24.28万
  • 项目类别:
In Vivo Reprogramming of Glial Fate for Spinal Cord Repair
体内神经胶质命运重编程用于脊髓修复
  • 批准号:
    9050713
  • 财政年份:
    2014
  • 资助金额:
    $ 24.28万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了